The growth inhibitory effects of the CaSR in breast cancer cells have been reported to be mediated by the downregulation of the expression of survivin, a well described anti-apoptotic factor in breast and other cancers (Liu et al., 2009; Promkan et al., 2011). Here, CASR is linked to breast cancer.